Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ASML reports third-quarter results on 14 October with the lending market utterly indifferent to the event. That near-total absence of short-side conviction, set against a week in which several close peers sold off sharply, is the most interesting tension heading into the print.
The borrow market offers no meaningful short-side story. Availability is effectively uncapped, with shares available to lend running at multiples of existing short interest. Cost to borrow has drifted back to 0.67% after a fleeting spike to around 1.4% on 23 September, a level that was itself contained and brief. The short score of 25.6 ranks in the bottom quarter of its universe, confirming that short sellers have no particular interest in the stock. This is not a market that is bracing for bad news.
The more telling signal this week is how ASML has behaved relative to its peer group. The stock gained roughly 0.8% on the week and closed at EUR 1,610.20 on 7 October, slipping 1.6% on the day but holding its ground overall. That compares with a rough five days for , which fell more than 8%, and , down nearly 12%. edged up around 1%, while , , and were broadly flat to slightly positive. ASML's outperformance on a week when several smaller and less differentiated equipment names got hit reflects a familiar dynamic: when the sector wobbles, capital tends to consolidate in the name with the clearest technology moat.
Valuation has continued to drift higher. The trailing price-to-earnings ratio now runs near 33x, up roughly 1 point over the past month, while EV/EBITDA has actually eased slightly to around 25.9x over the same period. The price-to-book ratio stands near 18.7x. These are not cheap multiples, and analyst data from the available record is too stale to be useful here. What is notable is ASML's factor profile: the dividend score ranks in the 97th percentile, and the short score ranks in the 96th percentile, meaning the stock screens as one of the least shorted names relative to its peers. The EV/EBIT factor is more middling at the 46th percentile, a quiet acknowledgement that the premium in the price is real.
Institutional ownership has been quietly building. BlackRock holds around 7.2% of shares, with a modest addition in the most recent period. Capital Research and Management added more than 670,000 shares in the period reported to end of September, one of the larger moves in the top-holder table. Norges Bank Investment Management and FMR have also been adding. On the insider side, the only open-market purchase in the past 90 days was a small supervisory board buy of 125 shares at EUR 1,556 in late July. The cluster of executive sells from February was grant-related, the kind of compensation mechanics that carry little directional signal.
The Q3 earnings history offers a thin but consistent pattern. ASML's last reported quarterly release, in July, produced a one-day move of around 2.7% to the upside, with a five-day follow-through of around 2.2%. The print on 14 October will therefore be less about whether the equipment cycle is intact and more about whether ASML's order book and EUV shipment cadence for 2027 are holding against the noise in the rest of the sector.
See the live data behind this article on ORTEX.
Open ASML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
